NCT07490509 2026-04-01
DOSABEMA
Poitiers University Hospital
Phase 4 Not yet recruiting
Clinical Trials
16 trialsNCT07257484 2026-03-13
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Weill Medical College of Cornell University
Phase 4 Not yet recruiting
NCT07436663 2026-02-27
SGLT2i/DPPi
Tanta University
Phase 4 Not yet recruiting
NCT07344974 2026-01-20
Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity
Peking University Cancer Hospital & Institute
Phase 4 Not yet recruiting
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT07162259 2025-09-09
Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer
Xi'an International Medical Center Hospital
Phase 4 Not yet recruiting
NCT05871437 2025-09-08
Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules
Fudan University
Phase 4 Not yet recruiting
NCT07093931 2025-07-30
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
Shandong Cancer Hospital and Institute
Phase 4 Not yet recruiting
NCT06777537 2025-01-16
Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer
Shandong University
Phase 4 Not yet recruiting
NCT06613373 2024-09-25
An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer
Jiangsu Famous Medical Technology Co., Ltd.
Phase 4 Not yet recruiting
NCT06578299 2024-08-29
Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer
Fudan University
Phase 4 Not yet recruiting
NCT06245824 2024-02-07
Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 4 Not yet recruiting
NCT05860907 2023-09-26
Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis
Fudan University
Phase 4 Not yet recruiting
NCT05841849 2023-05-03
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Not yet recruiting
NCT04929548 2022-01-05
Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP
Wuhan University
Phase 4 Not yet recruiting
NCT04137640 2021-07-20
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Shengjing Hospital
Phase 4 Not yet recruiting